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ABSTRACT
Nonuniform, mosaic expression patterns of trans-
genes are often linked to transcriptional silencing,
triggered by epigenetic modifications of the exoge-
nous DNA. Such phenotypes are common phenom-
ena in genetically engineered cells and organisms.
They are widely attributed to features of transgenic
transcription units distinct from endogenous genes,
rendering them particularly susceptible to epige-
netic downregulation. Contrary to this assumption
we show that the method used for the isolation of
stably transfected cells has the most profound
impact on transgene expression patterns. Standard
antibiotic selection was directly compared to cell
sorting for the establishment of stable cells. Only
the latter procedure could warrant a high degree
of uniformity and stability in gene expression.
Marker genes useful for the essential cell sorting
step encode mostly fluorescent proteins. However,
by combining this approach with site-specific
recombination, it can be applied to isolate stable
cell lines with the desired expression characteristics
for any gene of interest.
INTRODUCTION
The genomic integration of recombinant transcription
units is the standard technology for the genetic manipula-
tion of mammalian cells, both in basic research applica-
tions as well as in biotechnology (1,2). Once a stably
transfected cell clone has been identiﬁed, it should ideally
express the transgene in all cells, and at constant levels
over prolonged periods of time. Vastly diﬀerent expression
levels are frequently observed between individual clones.
These diﬀerences are attributed to either copy number
eﬀects or, more importantly, the particular chromosomal
integration site. Within a given clone, cell-to-cell variations
in expression levels (also referred to as mosaicism or var-
iegation) as well as complete cessation of gene expression
over time is quite common, despite the physical integrity
of the newly acquired transgene. In most cases the loss of
overall expression levels, or silencing, can be easily moni-
tored. In contrast, heterogeneity in expression often goes
unnoticed, either due to unawareness of the problem or
the lack of appropriate in situ tools for the detection
of mosaicism. The same problem applies to transgenic
animals, where mosaic expression patterns are also com-
mon. The interpretation of such variegated expression
patterns is greatly aided by the availability of dynamic
live cell reporter systems, allowing to repeatedly monitor
gene expression of a cell population, both quantitatively
and qualitatively. In comparison, a single ‘snapshot’ analy-
sis revealing a heterogenous expression pattern can result
either from (i) the asynchronous conversion of an expres-
sing to a nonexpressing cell population by gene silencing,
(ii) intrinsic ﬂuctuations of gene expression or (iii) a rather
stable distribution of expressing and nonexpressing cells.
Irrespective of the underlying process, variegation is often
an obstacle for the application of stable cell lines (3,4).
Progressive silencing and the generation of mosaic
expression patterns are often caused by epigenetic down-
regulation of transgenes. This process manifests itself via
DNA methylation and by locally restricted, covalent
modiﬁcations of histones, resulting in the formation of
repressive chromatin structures (5,6). The susceptibility
of exogenous transcription units to dynamic changes in
their epigenetic state is frequently ascribed to character-
istics of transgenes that distinguish them from endoge-
nous transcription units. Among the factors considered
are (i) the frequently observed high copy number of trans-
genes and the resulting tandem array integration pattern,
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
*To whom correspondence should be addressed. Tel: +49 30 94062596; Fax: +49 30 94062551; Email: mgossen@mdc-berlin.de
Present address:
Weimin L. Kaufman, Center for Pediatric Biomedical Research, University of Rochester, 601 Elmwood Ave., Rochester, NY 14642, USA
 2008 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.contributing to repeat-induced silencing, (ii) the nature of
the expression signals employed for transgenesis, espe-
cially the promoter choice and (iii) particular features of
the transgene itself, which can reside in the nucleotide
composition and sequence of the DNA transferred, like
the frequency and patterns of CpG dinucleotides. These
particularities of transgenes have been implied both in
variegated as well as in overall gene silencing (7–10). In
addition, it is also possible that a response of the host
cell is triggered by the actual DNA integration process
itself. This could result in the localized disruption of an
established chromatin context irrespective of particular
characteristics of the incoming DNA. It should be noted,
however, that mosaic expression patterns are not restricted
to transgenes, but have also been documented for endo-
genous genes. For a given gene analyzed, the cause for
such phenotypic variegation could be heterogeneity in
its local epigenetic environment within a cell population,
stochastic events contributing to its expression or dynamic
expression control mechanisms resulting in the oscillation
of its activity status (11–15). A more detailed understand-
ing of the interplay of these factors is not only of general
interest for the regulation of genome-wide transcription
programs, it may also provide us with a blueprint for the
design of transgenic transcription units and transgenesis
protocols less prone to undesired epigenetic modulation.
To this end, we initially set out to identify features of
transgenic transcription units that facilitate their homoge-
nous expression in stable cell lines. However, we found
that the method of enriching and isolating transgene-
positive cells had the greatest impact on homogeneity
and stability of gene expression. When compared directly
to a standard antibiotic selection regimen, cell populations
isolated by ﬂuorescence-activated cell sorting (FACS) on
the basis of ﬂuorescent protein expression showed little
cell-to-cell variation and the high levels of transgene
expression were remarkably stable over time. By using
site-speciﬁc recombinases, we were able to transfer these
qualitative expression parameters to other transgenes,
bypassing antibiotic selection protocols with their bias
towards mosaic expression patterns.
MATERIALS AND METHODS
Plasmid constructs
Plasmid pCMV-EGFP is a modiﬁed version of pEGFP-
C1 (Clontech, Mountain View, CA, USA), which was
used in initial experiments. Both vectors carrying a neo-
mycin antibiotic resistance marker gene under the control
of an SV40 promoter. Replacement of the CMV promoter
in pCMV-EGFP by the promoter of the human elonga-
tion factor 1a [EF1a from pEF1; (16)] resulted in pEF-
EGFP. In both plasmids the reporter cassette (promoter/
enhancer—EGFP—polyA signal) can be precisely excised.
For some of the experiments the plasmids were linearized
in the vector backbone. Plasmids allowing for the estab-
lishment of stable cell lines after sorting for ﬂuorescent
protein expression and recombinase-mediated deletion of
the marker gene do not contain an antibiotic resistance
marker gene for selection in mammalian cells. They are
based on a plasmid where EGFP, with its own polyadenyla-
tion signal, is ﬂanked by two FLP recombinase targets of the
F3 type (17) in the same orientation. Expression is controlled
by EF1a. The promoter-distal F3 site is followed by a multi-
ple cloning site (mcs) and the bovine growth hormone poly-
adenylation signal (pEFF3EGFPF3mcs; unique sites of the
mcs, promoter proximal to promoter distal: EcoRI, XmaI,
BamHI, SpeI, NotI, XhoI, NsiI). The mcs was used to
insert cDNAs of the monomeric red ﬂuorescent protein
[mRFP (18)] and the human transcription factor Oct4,
resulting in pEFF3EGFPF3mRFP and pEFF3EGFPF3Oct4,
respectively. Details of the plasmid construction (including
the complete vector sequences) are available upon request.
pCAGGS-FLPe was used for the transient expression of
an enhanced version of the FLP recombinase (19).
Cell cultureand transfections
Cells were cultured at 378C with 5% CO2 in minimal
essential medium containing 10% bovine serum, 2mM
L-glutamine, 50mg/ml penicillin and 50mg/ml streptomy-
cin. Doubling time was about 21h for HeLa cells and about
19h for CHO cells. G418 (Invitrogen, Carlsbad, CA, USA)
was used at a concentration of 400mg/ml. Subcloning by
limited dilution was achieved by seeding cells in 96-well
plates at a density of 0.2 cells/well. For both transient and
stable transfections the Roti-Fect liposome formulation
(Carl Roth GmbH, Karlsruhe, Germany) was used accord-
ing to the manufacturer’s protocol.
Flow cytometry and preparative FACS
Exponentially growing cells were harvested and resus-
pended in PBS supplemented with 0.1% EDTA.
Fluorescent protein expression was analyzed on a
FACSCalibur (BD Biosciences, San Jose, CA, USA) using
argon-ion laser excitation (488nm). EGFP was detected
using the FL1 parameter (emission ﬁlter: 53015nm) and
mRFP by using the FL2 parameter (emission ﬁlter
58521nm). Dead cells and debris were excluded from
the analysis by gating for intact cells using the forward
and sideward scatter. Untransfected cells were always
includedascontrol todetectautoﬂuorescence. Dataacquisi-
tionwascarriedoutbyanalyzing10000events/sampleusing
CellQuest Software (BD Biosciences). To enrich EGFP-
expressing cells, cells were sorted on a FACSVantage SE
( B DB i o s ci en c es ,C a r l s b a d ,C A ,U S A )w i t hﬂ u o r e s c en tp a r a-
meters identical to those described above. Cells were sorted
directly into growth media. FACS data were analyzed using
FlowJo Software (Tree Star, Inc., Ashland, OR, USA).
Immunoblot and immunofluorescence analysis
Immunoblot analysis for Oct4 expression was by standard
methods, using a goat antiserum directed against human
Oct3/4 (dilution 1:1000; R&D Systems, Minneapolis, MN,
USA) and a mouse monoclonal antibody directed against
a-tubulin (dilution 1:4000; Ab-1, Oncogene Science,
Cambridge, MA, USA) as a loading control. Signal detec-
tion was by enhanced chemiluminescence. The same anti-
bodies (anti-Oct3/4 at 1:200; antia-tubulin at 1:400) were
used for immunoﬂuorescence analysis of cells grown in
chamber slides (Lab-Tek #136439; Nalge Nunc, Naperville,
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0.1% Triton. Cy3-conjugated donkey antigoat antibody
and Cy2-conjugated donkey antimouse antibody (both
1:400; Jackson ImmunoResearch, West Grove, PA, USA)
were used as secondary reagents. Images were taken on a
DMI6000 B microscope (Leica, Wetzlar, Germany) using
a1 0  objective and a DFC 350 FX camera (Leica).
Fluorescence was detected with ﬁlters L5 and N2.1. Images
were processed by using the LAS AF application suite
1.6.2 (Leica). Image overlays were created using Adobe
Photoshop, version 7.0. For quantiﬁcation of EGFP expres-
sioninCHOcells,weanalyzedtotalcellextractsfromknown
numbers of cell by immunoblotting, in parallel with puriﬁed
EGFP protein (MBL, Woburn, MA, USA). Detection was
by using an rabbit antiserum against GFP (Invitrogen).
DNA and RNA analysis
Southern blotting was performed as described (20). For
real-time RT–PCR analysis, total RNA was isolated using
Trizol (Invitrogen) from Hela cells and the respective cell
lines stably transfected with pEFF3EGFPF3hOct4 before
and after FLP-recombination. The RNA was reverse tran-
scribed using Moloney murine leukemia virus reverse
transcriptase (Promega, Masison, WI, USA) according
to the manufacturer’s instructions. Real-time RT–PCR
was performed on the iCycler IQ TM 5 multicolor real-
time detection system (Bio-Rad, Hercules, CA, USA)
according to standard protocols, using ABsolute
TM
SYBR green ﬂuorescein (ABgene, Surrey, UK).
RESULTS
Isolation of stablytransfected cells byFACS
To facilitate a direct comparison between antibiotic selec-
tion and FACS for the isolation of cells expressing a trans-
gene after chromosomal integration, we ﬁrst analyzed two
cell populations derived from a single transfection experi-
ment. We used a plasmid harboring both a CMV promo-
ter driving expression of the green ﬂuorescent protein
(GFP), as well as a transcription unit conferring neomycin
resistance. After transfection of the linearized vector into
HeLa cells, its dual function enabled antibiotic selection of
G418-resistant cells and cell sorting for ﬂuorescent protein
expression in parallel experiments. FACS enrichment of
GFP-positive cells was done twice and the ﬂuorescence
level of the resulting cell population compared directly
to the GFP expression of pooled G418-resistant clones
originating from the same transfection. Figure 1 shows
that contrary to the sorted cell pool, the vast majority
of G418-resistant cells showed little to no GFP signal.
Microscopic examination of G418-resistant clones prior
to pooling had shown that the few GFP-positive cells
did not originate from a rare clone with intense GFP
expression, but that a low percentage of positive cells
was visible in several individual colonies. The high level
of GFP expression in the sorted cell pool showed only a
minor decrease when reanalyzed after growing those cells
for about 30 population doublings (PDs) without applying
selective pressure through addition of G418 (Figure 1). All
subsequent cell sorting experiments were done according
to the basic ﬂow chart outlined in Figure 1. We did not
notice any marked diﬀerence in the results when making
minor adjustments to the parameters indicated.
Characterization ofclonal cell lines
Next we analyzed clonal cell lines, derived from cell
sorted, GFP-positive pools by limited dilution. Their
mean ﬂuorescence values were compared with randomly
chosen clones obtained by standard antibiotic selection.
The results were in line with the analysis of the cell
pools, with G418-selected clones being either completely
GFP negative, or showing a weak GFP signal, often ori-
ginating from a limited number of positive cells. In con-
trast, subcloned isolates from the FACS protocol were all
positive for GFP expression according to quantitative ﬂow
cytometry (Figure 2A), and the majority of these clones
was also unambiguously positive by ﬂuorescence micro-
scopy. We thus analyzed clones derived by the FACS
protocol from cells transfected with a linearized pCMV-
EGFP vector for their homogeneity according to micro-
scopic inspection. More than one-third of the clones
isolated were judged to be uniformly GFP positive
(Figure 2B, left panel). In contrast, using the antibiotic
selection protocols, we were never able to isolate uni-
formly expressing clones from stably transfected HeLa
cells [see also (21) for comparison]. The ability to recover
nonvariegated cell clones with high conﬁdence allowed us
to address various parameters frequently discussed to have
a major impact on the formation of mosaic expression
patterns. First, we asked if bacterial vector sequences
have a major inﬂuence on transgene expression charac-
teristics. To this end we compared the results obtained
for the linearized pCMV-EGFP vector with that from
a CMV-EGFP expression cassette. The isolated CMV-
EGFP transcription unit (i.e. promoter, reporter gene
and polyadenylation signal) devoid of bacterial vector
sequences was transfected and cell lines were derived
after FACS and subcloning by limited dilution.
Figure 2B, middle panel, shows that a higher percentage
of homogenous GFP expressing clones could be recov-
ered. Second, the eﬃciency of obtaining such clones was
further improved by using a corresponding EF-EGFP
cassette, where the viral CMV promoter was exchanged
for the cellular EF1a promoter. This yielded about 80%
uniformly transgene-positive clones (Figure 2B, right
panel). Some of these latter clones were tested for the uni-
form expression persistence. They proved to be remark-
ably stable over >100 PDs (Figure 2C, upper panel),
similar to clones obtained after transfection of the
CMV-EGFP cassette (Figure 2C, middle panel). Note
that these cells do not contain a selectable resistance
marker. Thus, both CMV and EF1a promoters can
result in production of homogenous, long-term expressing
clones, although the EF1a promoter has a higher eﬃciency.
Interestingly, clones expressing the GFP gene under EF1a
control showed a higher uniformity in the ﬂuorescence
signal as compared to CMV-driven GFP-positive cell
clones. The same results for stability and homogeneity of
transgene expression were found when the experiments were
repeated with CHO cells using the linearized pCMV-EGFP
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the absolute expression levels observed, we determined in
one of the three CHO clones analyzed the EGFP levels by
quantitative immunoblot analysis. In this clone (indicated
in Figure 2C, lower panel) the level of EGFP was about
0.5pg per cell (about 10
7 molecules/cell).
In addition to the use of FACS for the isolation of
stable cell lines, the same results can be achieved by
using magnetic cell separation (MACS). We used a plas-
mid with CMV promoter driving expression of GFP, an
internal ribosome entry site, and a cell surface marker
gene, transcribed as a bicistronic mRNA [derived from
MACSelect
TM LNGFR System, Miltenyi Biotec, Bergisch
Gladbach, Germany; see also (22)]. Magnetic isolation of
transfected CHO cells was speciﬁc for expression of the cell
surface receptor, and was performed in two rounds prior to
cloning by limited dilution. Again, this procedure resulted
in a high proportion of clones uniformly and stably expres-
sing GFP, which was only used as an analytical marker,
not for cell sorting (W.L.K. and M.G., data not shown).
This demonstrates that the principle of stable cell line
generation we describe is not limited by the use of FACS.
However, in our hands the FACS approach was more
robust than MACS and thus was pursued further.
Cell sortingas ageneral tool inestablishing stable cell lines
We next asked if it is possible to adapt the approach
outlined here for the generation of stable cell lines for
transgenes that do not convey a sortable cellular pheno-
type. To this end, we constructed expression units as
outlined in Figure 3A. Here, EF1a drives expression of
a GFP gene ﬂanked by FRT sites arranged in the same
orientation. Upon FLP recombination, the promoter
proximal GFP gene and its polyadenylation signal will
be deleted and a distal, previously not transcribed gene
of interest would be placed under control of the EF pro-
moter. To test this principle in an experimental setting
that would allow us to directly monitor the succession of
events, we initially chose a red ﬂuorescent protein (RFP)
gene. Cells were transfected and sorted for GFP expres-
sion and individual clones characterized for homogeneity
and persistence of the GFP signal. These RFP-negative
cells were transfected with a vector encoding enhanced
FLP (19). Recombinase expression caused deletion of
GFP and placement of RFP under EF1a control, as
indicated by previously green cells turning to red
(Figure 3B). The deletion event was also monitored by
Southern blotting (Figure 3C). After recloning, all of the
Figure 1. Flow chart of FACS and antibiotic-selection protocols. HeLa cells were transfected with pEGFP-C1. One day posttransfection (d.p.t.) the cells
were divided, with one aliquot subjected to G418 selection to obtain a stably transfected cell population. The other aliquot of cells was grown in the
absence of antibiotic selection, and cells were initially subjected to cell sorting for EGFP expressers at 4d.p.t. The sorting gate and percentage of sorted
cells of the whole population is indicated in the right inset showing the FACS proﬁle for the ﬂuorescence signal. Due to the transient nature of EGFP
expression at this time point, the majority of the gated population lost the reporter gene expression when grown without antibiotic selection until the
second cell sorting at 11d.p.t. The residual positive population was expanded and analyzed for ﬂuorescent protein expression in parallel with the
population grown under drug selection, obtained by pooling all G418-resistant colonies. The FACS proﬁles at the bottom show the ﬂuorescence signals
from the pools of transfected cells (black line) in comparison to untransfected, parental HeLa cells (grey line). Further growth of the sorted population for
30 population doublings without selective pressure resulted only in a minor loss of the EGFP signal (grey-ﬁlled area in bottom right FACS proﬁle).
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positive, and maintained this expression pattern
(Figure 3D).
Having shown the proof of principle, we turned to the
expression of human oct4, the homogenous expression of
which is of immediate relevance for the ongoing work in
our laboratory. The human oct 4 gene was placed behind
the FRT-ﬂanked GFP cassette. Generation of stable,
homogenous GFP-positive HeLa cell clones with a non-
transcribed oct4 gene was as described before. HeLa cells
were chosen as they are otherwise negative for oct4 expres-
sion. FLP-mediated deletion of the reporter cassette
caused a decrease in the GFP signal of the transfected
subpopulation (Figure 4A). Subsequent recloning resulted
in transgene expression in 2 out of 3 subclones analyzed,
as shown by immunoblot analysis for Oct4 (Figure 4B).
We corroborated these results by quantitative analysis of
the oct4 transcript levels. cDNA obtained from total RNA
was analyzed by qPCR. As shown in Figure 4C, the oct4
RNA levels of HeLa cells stably transfected with
pEFF3EGFPF3Oct4 was barely above the low levels
found in the parental HeLa cells. FLP-mediated cassette
deletion resulted in a strong signal for the oct4 transcript.
Lastly, the homogeneity of transgene expression was
Figure 2. Characterization of clonal cell lines. Cell pools isolated by FACS were cloned by limited dilution and GFP expression patterns analyzed by ﬂow
cytometry and ﬂuorescence microscopy. (A) Comparison of GFP expression levels (mean ﬂuorescence) of randomly chosen clones, derived either from
G418 selection or FACS as outlined in Figure 1. The background autoﬂuorescence of untransfected cells is indicated by a dashed line. (B) Analysis of
transgene expression patterns (homogenously positive/heterogeneously positive/negative) according to microscopic analysis of GFP signals. The left
panel shows the results for a linearized pCMV-EGFP vector, the middle panel for a corresponding expression cassette devoid of all plasmid backbone
sequences. The right panel shows the results for such an expression cassette incorporating the EF promoter instead of the CMV promoter. The sample
numbers of individual clones analyzed is indicated. (C) Clones derived from transfections with either EF or CMV expression units as indicated and that
were judged homogenously positive by microscopy were analyzed for homogeneity of transgene expression over time. The diﬀerent time points of ﬂow
cytometric GFP proﬁling during continuous culturing of three independent clones for each experiment are indicated. The upper two panels depict HeLa
cell clones, the lower panel CHO cell clones, with the one labeled by an asterisk used for quantitative immunoblotting.
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tein. Prior to deletion of the GFP cassette, HeLa cells
stably transfected with pEFF3EGFPF3Oct4 did not show
a discernable Oct4 signal, in line with the immunoblot
analysis. In contrast, after FLP-mediated deletion of the
reporter cassette, clonal cells were uniformly positive for
Oct4, with the transcription factor accumulating in the
nucleus (Figure 4D).
We conclude from this series of experiments that
qualitative parameters as identiﬁed for the expression of
a reporter gene can be transferred to a physically linked
gene of interest by the experimental approach outlined.
DISCUSSION
The diﬀerence between ‘stable cell lines’ and ‘stable stable
cell lines’ has been pointed out previously (23). This view
of recombinant clonal cell populations and their tendency
to silence transgene expression over time refers to the loss
of net expression levels from engineered transgenes. While
such a silencing might be gradual but homogenous, it can
as well be restricted to a subpopulation among the cells. In
general, such phenomena are attributed to epigenetic
modulations of transgene activity in tissue cultures and
transgenic animals. The interpretation of mosaic expres-
sion patterns in animals is complicated by the possibility
that variegation might be caused by diﬀerentiation events,
resulting in tissue microheterogeneity not uncovered by
obvious histological changes. We, therefore, focused on
analyzing transgene silencing in stably transfected cell
lines, where a better understanding of this process might
help us to bypass it. Our previous results showed that the
Figure 3. Recombinase-mediated switch of transgene expression. (A)
Schematic presentation of the expression vectors for FLP-mediated
switch of transgene expression used in this study. Genes of interest
(GOI) inserted by us in the multiple cloning sites (mcs) were oct4 and
mRFP. The deletion principle is outlined for the latter transgene, with the
transcripts before and after recombination indicated. (B) Cells stably
transfected with pEFF3EGFPF3mRFP were followed over the time
course of a deletion experiment, showing both the GFP and RFP signals.
Left panel: only EGFP was expressed. Middle panel: in cells where FLP
levels upon transient transfection were suﬃcient to promote EGFP dele-
tion, mRFP expression was activated. Untransfected cells stayed green.
Right panel: recloning after FLP expression showed that GFP-negative
clones were uniformly positive for RFP. (C) Southern blot analysis of a
selected pEFF3EGFPF3mRFP clone before FLP-mediated recombination
and a corresponding subclone after deletion of the EGFP reporter. The
hybridization probe used is the mRFP gene. Note that the signal intensity
for the mRFP target sequence decreased twofold after recombina-
tion (phosphorimager signal 246 versus 137 arbitrary units). The recom-
bination principle anticipates a reduction of inserts to single copy
transgenes. (D) The switch from GFP to RFP expression as monitored
by ﬂow cytometry.
Figure 4. Homogenous expression of Oct4. (A) A homogenously GFP-
positive pEFF3EGFPF3hOct4 clone is shown in the top panel. Three days
after transfection of a FLP expression vector a bimodal GFP pattern can
be recognized (bottom panel), as FLP expressing cells show a progressive
loss of the GFP signal upon reporter gene deletion. (B) Immunoblot
analysis for Oct4 expression. Neither the parental cell line nor the non-
recombined pEFF3EGFPF3hOct4 clone expressed detectable levels of
Oct4. Of the three subclones isolated after FLP-mediated EGFP deletion,
two showed a strong Oct4 signal. (C) RNA isolated from the parental cell
line, the nonrecombined and a recombined pEFF3EGFPF3hOct4 clone
was analyzed for Oct4-speciﬁc transcript levels by qPCR. (D) After
FLP-mediated recombination, Oct4 (shown in blue) can be found in
every nucleus of a pEFF3EGFPF3hOct4 subclone (lower panel), contrary
to the initial, nonrecombined pEFF3EGFPF3hOct4 clone (upper panel)
that was Oct4 negative. The counter stain in this immunoﬂuorescence
analysis was tubulin, shown in yellow.
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chromosome loci did not ensure identical phenotypic
characteristics of the isogenic cell lines generated. Even
when a targeting event resulted in homogenous reporter
gene expression in presence of antibiotics imposing selec-
tive pressure, in most of these clones mosaic gene silencing
started when this selective pressure was removed (20).
These and other observations indicate that standard trans-
fection procedures mostly result in integration events in
chromosomal loci that do not warrant constant transgene
expression, in particular without selection for a cointe-
grated resistance marker gene. Mosaic expression patterns
are often a consequence of dynamic epigenetic settings
proximal to the transgene. It is reasonable to assume
that selection marker genes at these sites show similar
expression patterns. Drug selection would result in a pro-
liferative advantage for the subset of cells expressing an
antibiotic resistance gene at a given time, rather than
actively fending oﬀ the dominant inﬂuence of repressive
chromatin structures. While such loci might still show a
drug-selection enforceable, ostensible stability of gene
expression, they are clearly not suited to support the ana-
lysis of transgenic cis elements contributing to mosaicism.
With our approach, cell lines were isolated on the basis
of persistent transgene expression in the ﬁrst place, and
not by antibiotic resistance. We assume that they would
depend on favorable integration sites that are not exposed
to such invasion of repressive chromatin modiﬁcations or
potentially also DNA methylation.
To test this concept we generated stable cell lines using
GFP as a sortable marker protein for FACS. Far from
establishing itself as a routine procedure, the potential of
this methodology for the generation of stable cell lines has
been demonstrated, often also in the enrichment of sub-
populations of cells showing particular high expression
levels (24–30). Starting from a single transfection of a
standard GFP reporter construct, we showed a direct
comparison between a cell sorting- and an antibiotic
selection-based approach for the generation of stable
cell lines. GFP-positive cells in sorted cell population
appeared at a much higher frequency as compared to
those obtained by drug selection. This is the expected
consequence of the isolation procedure, which is based
directly on the expression of the ﬂuorescent protein.
However, even after clonal outgrowth, positive cell lines
showed homogenous, stable GFP expression in absence of
selective agents, unlike the cell lines obtained by standard
drug selection procedures. Our interpretation is that the
cell sorting and subcloning procedure described will spe-
ciﬁcally enrich for integration events in chromosomal loci,
where transgenes are invisible to cellular mechanisms
responsible for triggering or mediating silencing, allowing
them to ‘survive’ repeated cell sorting. It will be interesting
to identify these favorable chromosomal sites for trans-
gene integration and determine their localization relative
to functional entities within the genome (e.g. transcription
units, matrix attachment regions, heterochromatic
regions) and use well characterized loci with the desirable
properties for retargeting by chromosome engineering
(31,32). Our parallel experiments using a drug-selection
protocol demonstrate that these integration events are
lost in the course of antibiotic selection. With its own
transcription unit, the criteria for resistance marker
expression obviously do not coincide with those for a
independently expressed gene of interest, even when
placed in close proximity. Threshold eﬀects in mediating
drug resistance as compared to the quantitative readout
possible by cell sorting may also contribute to the appar-
ent imbalance of integration sites recovered through the
diﬀerent protocols.
The isolation of stably transfected cells by FACS-based
cell sorting for GFP-expressing cells and the resulting
enrichment of transgenes integrated in a favorable chro-
matin environment is obviously also a form of selection.
One could argue that given the readout used, this isolation
procedure is simply a more stringent selection principle
than the drug selection used by us. More stringent and
quantitative drug-based approaches for cell line selection
might therefore also improve the performance of stable
transformants. Without having tested this directly, both
the outcome of our experiments as well as the concept of
designing any given selection scheme based on the gene of
interest itself, already argue that the integration of sorting
strategies in gene transfer protocols should be considered
an attractive experimental option in general.
Whatever the exact requirements for persistent, uniform
expression of transgenes might be, it is clear that such
conditions are not necessarily precluded by some of the
factors often suspected to contribute to mosaicism and
transcriptional silencing. For example, bacterial vector
sequences have been implicated to play a major role in
these processes (33–36) and viral enhancer elements like
that found in the CMV immediate early promoter are
often deemed to be more susceptible to silencing than
cellullar expression signals like the EF promoter, both
in vitro and in vivo (34,37–39). Such a trend was also
seen in our experiments using FACS, where the use of
the CMV promoter as well as inclusion of the plasmid
backbone had a negative eﬀect on the uniformity of
gene expression. However, this eﬀect was rather small
and clearly did not prevent formation of homogenously
positive clones under these conditions.
Cell line generation with FACS or MACS is mostly
restricted to transgenes amenable to the respective separa-
tion principle. This limitation can be overcome by the
recombinase-mediated deletion of the sortable marker
gene, reminiscent of stop cassettes mostly used to con-
ditionally activate transgenes in mice, depending on a
recombinase expression pattern (40). Related strategies
have also been described for cell lines (41,42). Such
approaches have the additional advantage that they facil-
itate the creation of stable genetic conditions without
expression of the transgene of interest itself, circumventing
possible negative eﬀects on proliferation during cell line
establishment. Our solution for stable expression of non-
sortable genes is not limited to using strong constitutive
promoters meant to facilitate cell sorting. The EF1a pro-
moter can also be placed together with the GFP marker
between the ﬂanking FRT sites. Upon deletion of this
whole transcription unit, any upstream promoter (e.g. an
inducible or cell type speciﬁc) could take over expression
of the gene of interest.
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presented here can be widely applied, resulting in clones
displaying expression characteristics often exceedingly dif-
ﬁcult to obtain by antibiotic-enforced selection protocols.
The basic procedure of isolating cell clones (repeated
FACS, subcloning, reporter deletion and recloning) can
be completed in about 6 weeks. Depending on the ques-
tions asked or the problem confronted with, establishing
such cell lines will often be a worthwhile investment of
time. It will be interesting to further evaluate cell sorting
as the basic principle for generating cell lines as an addi-
tional parameter in optimizing recombinant protein pro-
duction (43). Other examples for the utility of this route of
cell line production include the need to grow cells under
antibiotic-free conditions, be it to minimize cellular stress
(44) or to eliminate the risk of antibiotic contaminants in
industrial fermentation processes. For cell-based assays,
the issue of homogenous transgene expression can also
have signiﬁcant consequences. While heterogeneous trans-
gene expression might be acceptable when transgene
expression results in an activation of a cellular response,
it is unacceptable if the expressed transgene is e.g. a repres-
sor protein or a microRNA, downregulating particular
cellular targets. Assuming expression exists in only half
of the cells, the response as measured for the cell popula-
tion will never exceed a factor of two. This will frequently
be prohibitive for any kind of conclusive analysis and
emphasizes the need to control the variability of transgene
expression in cellular systems.
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